GENEMATRIX INC. Logo

GENEMATRIX INC.

Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.

109820 | KO

Overview

Corporate Details

ISIN(s):
KR7109820001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 700 삼평동 코리아바이오파크 8층,7층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GeneMatrix Inc. is a biomedical company specializing in multiplex molecular diagnostics. Founded in 2000, the company develops innovative diagnostic products based on its core multiplex real-time PCR platform technology. Its flagship NeoPlex™ product line features assays designed for the simultaneous detection of multiple pathogens from a single sample, offering fast, accurate, and cost-effective solutions for various infectious diseases, including respiratory illnesses, HPV, and tuberculosis. Alongside its focus on diagnostics, GeneMatrix also engages in the development of new drugs and therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 815.6 KB
2025-06-16 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획자진취하등) (GMJI-01의 국내 제1상 임상시험계획 승인신청 자진취하)
Korean 13.9 KB
2025-06-02 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 881.6 KB
2025-04-21 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (GMAI-02의 국내 제1상 임상시험계획승인)
Korean 13.4 KB
2025-04-14 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.0 KB
2025-04-02 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.2 KB
2025-04-02 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.0 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.4 KB
2025-03-21 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.2 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 332.8 KB
2025-03-10 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 13.3 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.5 KB

Automate Your Workflow. Get a real-time feed of all GENEMATRIX INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEMATRIX INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEMATRIX INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.